drugset / Trial / NCT04942275

Lung Perfusion PET / CT Using Ga68-MAA for Preservation of Lung Function During Stereotactic Pulmonary Radiation Therapy

NCT04942275 ↗

Phase 2/3 Unknown 60 enrolled University Hospital, Brest
NaSingle-groupOpen-labelOther

Summary

This is a prospective study evaluating the feasibility of treatment planning integrating lung perfusion PET/CT using Ga68-MAA to preserve functional lung areas during stereotactic body radiation therapy (SBRT).

Timeline

Start
2021-07-15
Primary completion
2022-07-30
Completion
2023-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject 68Ga-MAA Diagnostic / imaging agent — Intravenous